A drug that works against HER2-positive breast cancers by blocking the ability of the cancer cells to receive chemical signals that tell the cells to grow. It is a type of targeted therapy that belongs to a group of drugs called HER2 (human epidermal receptor 2) inhibitors.
Read more about Tykerb (chemical name: lapatinib).
Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.
Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003
©2012 Breastcancer.org - All rights reserved.
